open12noTo optimise treatment of patients with pulmonary arterial hypertension (PAH), the 2015 European Society of Cardiology/European Respiratory Society guidelines recommend using risk stratification, with the aim of patients achieving low-risk status. Previous analyses of registries made progress in using risk stratification approaches, however, the focus is often on patients with a low-risk prognosis, whereas most PAH patients are in intermediate-risk or high-risk categories. Using only six parameters with high prognostic relevance, we aimed to demonstrate a pragmatic approach to individual patient risk assessment to discriminate between patients at low risk, intermediate risk and high risk of death.This work was supported by Department...
Aims: Estimation of prognosis in pulmonary arterial hypertension (PAH) has been influenced by that v...
The 2015 European Society of Cardiology/European Respiratory Society guidelines for the diagnosis an...
BACKGROUND: Approaches to risk assessment in pulmonary arterial hypertension (PAH) include the nonin...
To optimise treatment of patients with pulmonary arterial hypertension (PAH), the 2015 European Soci...
The 2015 European pulmonary hypertension (PH) guidelines propose a risk stratification strategy for ...
The 2015 European pulmonary hypertension (PH) guidelines propose a risk stratification strategy for ...
The 2015 European pulmonary hypertension (PH) guidelines propose a risk stratification strategy for ...
BACKGROUND: Risk stratification plays an essential role in the management of patients with pulmonary...
Background: Risk stratification plays an essential role in the management of patients with pulmonary...
BACKGROUND: Risk stratification plays an essential role in the management of patients with pulmonary...
International audienceIntroduction Contemporary risk assessment tools categorise patients with pulmo...
BACKGROUND: Risk stratification plays an essential role in the management of patients with pulmonary...
Regular patient assessment is essential for the management of chronic diseases, such as pulmonary ar...
OBJECTIVE: Risk stratification continues to evolve in pulmonary arterial hypertension (PAH). Our aim...
In the summer of 2016, delegates from the German Respiratory Society, the German Society of Cardiolo...
Aims: Estimation of prognosis in pulmonary arterial hypertension (PAH) has been influenced by that v...
The 2015 European Society of Cardiology/European Respiratory Society guidelines for the diagnosis an...
BACKGROUND: Approaches to risk assessment in pulmonary arterial hypertension (PAH) include the nonin...
To optimise treatment of patients with pulmonary arterial hypertension (PAH), the 2015 European Soci...
The 2015 European pulmonary hypertension (PH) guidelines propose a risk stratification strategy for ...
The 2015 European pulmonary hypertension (PH) guidelines propose a risk stratification strategy for ...
The 2015 European pulmonary hypertension (PH) guidelines propose a risk stratification strategy for ...
BACKGROUND: Risk stratification plays an essential role in the management of patients with pulmonary...
Background: Risk stratification plays an essential role in the management of patients with pulmonary...
BACKGROUND: Risk stratification plays an essential role in the management of patients with pulmonary...
International audienceIntroduction Contemporary risk assessment tools categorise patients with pulmo...
BACKGROUND: Risk stratification plays an essential role in the management of patients with pulmonary...
Regular patient assessment is essential for the management of chronic diseases, such as pulmonary ar...
OBJECTIVE: Risk stratification continues to evolve in pulmonary arterial hypertension (PAH). Our aim...
In the summer of 2016, delegates from the German Respiratory Society, the German Society of Cardiolo...
Aims: Estimation of prognosis in pulmonary arterial hypertension (PAH) has been influenced by that v...
The 2015 European Society of Cardiology/European Respiratory Society guidelines for the diagnosis an...
BACKGROUND: Approaches to risk assessment in pulmonary arterial hypertension (PAH) include the nonin...